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Choice of lens materials and solutionsCONTACT LENSES 
S ince their introduction in the late 1980s, multipurpose lens 
care systems (MPS) have become 
the ﬁrst choice for contact lens 
care.1 Simplicity of use is the most 
likely reason for their preference 
but that should not be the sole 
reason for a successful lens care 
system, as other important attrib-
utes are needed:
• effective against microbes
• non-toxic to user
• fast action cycle
• compatible with the corneal
epithelium
• compatible with all lens materi-
als
• establishes stable pre- and post-
lens tear ﬁlms
• enhances comfort: minimising
lens deposition, conditioning
the lens surface, and maintain-
ing lens hydration 
• inexpensive.
The challenge in delivering
these attributes is that some may 
impact others; an increasing ef-
fectiveness against microbes may 
lead to an increase in epithelial 
toxicity. Finding this balance is a 
challenge for the manufacturers 
and we all know that every patient 
is different in their physiology and 
their use of the system.
While all of these attributes are 
important in a lens care system, if 
each of us were asked to rank them 
Figure 1. Solution induced corneal staining, superﬁcial punctate stain-
ing following lens removal and instillation of sodium ﬂuorescein 
Photo: Centre for Contact Lens Research
Figure 2. Solution induced corneal staining, following lens removal and 
prior to the instillation of sodium ﬂuorescein 
Photo: Centre for Contact Lens Research
in order of preference, we would 
be likely to all have a different 
ranking. Ideally, we would agree 
that the MPS must maintain the 
lens’s condition and its surface, 
be efficacious against microbes 
and not compromise the corneal 
epithelium.
Delivering an effective MPS has 
resulted in different approaches by 
the manufacturers and affords the 
optometrist a reasonable selection 
of products for their patients.
A practitioner must consider 
many aspects of lens maintenance, 
performance and patient comfort 
when determining which lens 
care system is best. It would be a 
poor clinical decision to assume or 
decide that MPS are all the same 
and simply recommend only one.
The interactivity between the 
lens material and surface with the 
MPS has given rise to much debate 
over the past few years. Cases in 
point are whether the incidence 
of corneal inﬁltrates is increas-
ing, and the heated debate on the 
appearance of solution induced 
corneal staining (SICS).
SICS is characterised by the 
observation of superﬁcial punctate 
staining on lens removal (Figure 
1). The observation is optimised 
following two hours of lens wear.2,3
This was ﬁrst reported by Jones 
and colleagues4 and its appearance 
has been repeatedly demonstrated 
since.5,6,7 Andrasko has the pro-
tocol for the observation of SICS 
optimised and described on his 
website (www.staininggrid.com), 
along with the extent of the ap-
pearance of SICS that has been 
induced for most lens materials 
and MPS. 
What is not clear is the impact 
of lens age on SICS. Does its ap-
pearance worsen or reduce? There 
is also debate on whether SICS is 
symptomatic or asymptomatic and 
whether that reﬂects the signiﬁ-
cance of this ﬁnding.5,7 Some stud-
ies suggest SICS is associated with 
corneal inﬂammatory responses 
(inﬁltrates).8,9
There is also an alternative 
view on this condition, which has 
resulted in an alternative name, 
preservative associated transient 
hyperﬂuorescence or PATH.10 This 
theory suggests the apparent ﬂuo-
rescence is due to the formation of 
a chemical complex between the 
preservative (PHMB) and sodium 
ﬂuorescein.
This chemical complex wrap-
ping around epithelial cells and 
giving the appearance of corneal 
staining is in fact not staining. The 
PATH theory suggests the observa-
tion you make on lens removal is 
an artefact of your instillation of 
the ﬂuorescein.
What can we make of this situa-
tion? What should we do? 
There is confusion in the lit-
erature regarding this and as a 
practitioner, we have to provide 
Clinical judgment and SICS
Craig A Woods 
PhD MCOptom FAAO FACO 
Associate Professor, Director of 
 Optometric Clinical Studies, Deakin 
Optometry, School of Medicine,  
Deakin University
Continued page 14
14 Australian Optometry   May 2013
CONTACT LENSES Multi-purpose solutions
H aving worked in the contact lens industry for 33 years, I 
have seen many structural chang-
es, from manufacturing through 
to retailing. 
Experiencing manufacturing 
progression before and after com-
puterisation was exciting and 
made me realise the advances 
that can be achieved through 
technology.
Implementation was challenging 
and information booklets were 
key to successful use. The need 
to fully understand new product 
features often meant considerable 
time was spent studying, to grasp 
key points and avert the risk of 
under- or non-use.
Customer service and techni-
cal support feedback highlight 
the importance of instruction for 
successful uptake on many new 
purchases. These can range from 
new computer programs and cor-
neal topographers, through to RGP 
diagnostic ﬁtting kits.
Some products require steep 
learning curves to understand the 
information guidelines provided. 
If the guidelines are not easy to 
use, important points may be over 
looked, resulting in increased 
 reliance on customer support.
Without straightforward and 
convenient information and ad-
vice, practitioners might feel hesi-
tant during busy periods to fully 
embrace these new technologies, 
perhaps dabbling in a product 
and not fully optimising business 
opportunities. 
How can industry better assist 
end-users with information to 
avert such scenarios? This is a 
challenge being undertaken by 
Innovative Contacts.
Having orthokeratology covered 
in a complete range with Global 
OrthoK Vision (GOV) single vi-
sion, multifocal myopic and hy-
peropic designs; plus Innovative 
Contacts’ ‘Forge’ custom sphere, 
toric and quadrant designs, is 
impressive but could be seen as 
daunting.
We consider it imperative to 
help practitioners become con-
ﬁdant to explore more lucrative 
ranges, by providing technical 
ﬁtting aids. 
‘EyeSpace’ lens design software 
is to be launched soon, aimed at 
corneal topography analysis for 
optimum RGP simulated ﬁtting.
Tools such as EyeSpace and a 
wide variety of online learning 
packages will help practitioners 
overcome many barriers. 
Popular information options can 
include written and pictorial step 
H yaluronan (HA), one of the natural lubricants of the eye, 
provides ocular hydration and 
contributes to stabilisation of 
preocular tear ﬁlm1 and has been 
shown to be retained and released 
by contact lenses.2 
While it has been reported that 
decreased HA concentrations 
may result from contact lens 
wear,3 the HA concentrations 
in tear ﬁlm have not yet been 
evaluated after wear of contact 
lenses that have been soaked in 
a multi-purpose solution (MPS) 
containing HA. 
This study evaluates the concen-
tration of HA in tear ﬁlm of contact 
lens wearers and non-contact lens 
wearers. It also determines if use 
of Biotrue Multi-purpose solution 
containing HA can affect the con-
centration of HA in tears.
Methods
Twenty-ﬁve subjects matched for 
age and gender (12 habitual lens 
wearers and 13 non-lens wearers) 
participated in this randomised, 
single-masked, contralateral study. 
Contact lens wearers were divided 
into two test groups, one wear-
ing control lenses (senoﬁlcon A) 
rinsed with Sensitive Eyes Saline 
Tears, and one wearing contact 
lenses (senoﬁlcon A) soaked over-
night in Biotrue MPS for 14 hours.
formed to natural log values to 
closer approximate normal distri-
bution and a mixed effects model 
was employed to account for cor-
relations due to multiple observa-
tions of the same subjects.
Concentration of HA in tears at baseline and collected from eyes that 
had worn contact lenses soaked in Biotrue MPS and in saline rinsed 
controls
Saline/lens
Biotrue/lens
Baseline
Mean ng hyaluronan/ml tears
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A repeated measurement ANO-
VA model was used to evaluate 
differences in HA concentrations. 
Comparisons with p-values 
0.05 were considered statistically 
different.
Results
HA concentrations obtained in 
this study ranged from undetected 
to 3018 ng HA/ml tears which is 
in range with previously reported 
measurements.1 No statistical 
differences in baseline HA were 
noted between lens wearers and 
non-lens wearers in this study 
population. 
Similarly, there was no statis-
tical difference between saline 
rinsed control lenses and base-
line. Gender and dichotomised 
dry eye ratings were not signiﬁ-
cantly associated with HA con-
centration. 
There was a signiﬁcant nega-
tive association between age and 
HA concentration (the older the 
subject, the lower the HA con-
centration), with contact lens 
wear contributing most to this 
association. 
An increase in HA concentration 
was observed in tears collected 
from eyes that had worn contact 
lenses soaked in Biotrue MPS 
compared to baseline (p = 0.009), 
and compared to those with saline 
rinsed control contact lenses (p = 
0.033) (Figure).
Conclusions
This study shows that after wear-
ing senoﬁlcon A contact lenses 
soaked in Biotrue Multi-purpose 
solution, an HA-containing care 
system, the HA concentration in 
tear ﬁlm was signiﬁcantly higher 
than baseline or after wearing 
lenses rinsed with saline. The 
duration of HA increase was not 
evaluated.
This study also suggests that 
there may be no signiﬁcant differ-
ences in tear ﬁlm HA concentra-
tion between contact lens wearers 
and non-contact lens wearers.
Biotrue multi-purpose solution 
is formulated to work like the eye 
with three bio-inspired innova-
tions.4-7 It works like the eyes to 
help contact lenses stay clean7,9 
and moist for all day comfort9 to 
make contact lens wear easier on 
the eyes.4
References available on request to 
r.riches@optometrists.asn.au
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Director, Innovative Contacts
guides, web links, tutorial webi-
nars, FAQs, blogs, flow charts, 
workshops and customer service 
technical phone support.
These tools will help improve 
product knowledge while en-
couraging use, maximising initial 
success and giving business ef-
ﬁciencies to all parties with mini-
mum patient inconvenience.
Everyone’s aim is to provide 
patients with leading products and 
services for best eye care health 
and comfortable lifestyle vision 
correction options.
Gaining business growth through 
technology while achieving some 
internet purchasing insulation is 
also important and can create an 
exciting opportunity for our great 
industry. 
It is vital to start or modify now 
an existing business model for 
such growth, as it takes time to 
reposition practices faced with an 
increasingly competitive future. 
Purchasing the latest equipment, 
technologies and products is all 
part of the business differentiation 
story, which if not fully embraced 
may result in missed opportuni-
ties. 
With industry and practitioners 
joining forces to optimise and im-
plement optometric advances, we 
can ensure personal growth and 
rewards while still maximising 
business success.
Tears were collected from both 
groups on Schirmer strips at base-
line and after two hours of contact 
lens wear. HA concentrations were 
measured by enzyme-linked im-
muno sorbent assay (ELISA) and 
adjusted for sample volumes. 
HA concentrations were trans-
Continuous variables were ana-
lysed with a linear regression 
mixed effects model with log HA 
as the outcome variable. Categori-
cal variables were analysed with 
a repeated measurement ANOVA 
model with log HA as the outcome 
variable. 
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appropriate care for our pa-
tients and base these decisions 
on the best evidence available 
to us. 
What is my advice? I have 
always set the goal of ‘do no 
harm’ to my patients and to 
provide them with the best 
care possible. This means I 
select the most appropriate 
lens material for my patient 
and that alone may impact my 
choice of MPS.
During after-care and follow-
up visits, I perform a slitlamp 
assessment under white light 
with the lens removed and 
then with ﬂuorescein instilled. 
When I observe the appearance 
of white specks with white 
light (Figure 2), which then 
appear as staining with ﬂuores-
cein (Figure 1), I conclude that 
I am seeing SICS and not PATH 
or corneal inﬁltrates.
It cannot be PATH as it is 
observable without the aid of 
a diagnostic dye, neither is 
it an inﬁltrate as it is clearly 
of the anterior epithelium. In 
this situation I start looking to 
resolve the problem and nine 
times out of 10 this requires me 
to change the MPS rather than 
the lens material.
I am loath to change a lens 
material or design that is other-
wise performing for the patient. 
My preference is to change the 
lens care system to one with 
demonstrated reduced likeli-
hood of inducing SICS with that 
lens material.
Reviewing the literature af-
fords us a few strategies in re-
ducing the appearance of SICS:
• change MPS to one that has 
less SICS with the lens mate-
rial11 (see Andrasko staining 
grid, www.staininggrid.com)
• wear the lens prior to use of 
the MPS12
• rub and rinse the lens prior 
to the overnight soaking 
 period.13
Minimising any potential 
physiological compromise in-
tuitively should lead to happier 
and healthier lens wear and 
patients. 
Ensuring ocular compatibil-
ity with the lens care system as 
well as the lens material must 
surely address the primary rea-
son for lens discontinuation, 
which is lens discomfort.14 
This article was sponsored by 
Alcon.
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